These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Panel seeks better monitoring of experiments using people. Hilts PJ N Y Times Web; 2000 Mar; ():A20. PubMed ID: 11873787 [No Abstract] [Full Text] [Related]
28. Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD). Batshaw ML; Wilson JM; Raper S; Yudkoff M; Robinson MB Hum Gene Ther; 1999 Sep; 10(14):2419-37. PubMed ID: 10515461 [No Abstract] [Full Text] [Related]
29. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'. Smaglik P Nature; 1999 Dec; 402(6763):707. PubMed ID: 10617181 [No Abstract] [Full Text] [Related]
30. A tumultuous year for gene therapy. Verma IM Mol Ther; 2000 Nov; 2(5):415-6. PubMed ID: 11082313 [No Abstract] [Full Text] [Related]
31. Researchers and regulators reflect on first gene therapy death. Hollon T Nat Med; 2000 Jan; 6(1):6. PubMed ID: 10613797 [No Abstract] [Full Text] [Related]
32. Gene therapy trials face further scrutiny. Greener M Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374 [No Abstract] [Full Text] [Related]
33. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health. Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602 [No Abstract] [Full Text] [Related]
34. NIH under fire over gene-therapy trials.. Wadman M Nature; 2000 Jan; 403(6767):237. PubMed ID: 10659820 [No Abstract] [Full Text] [Related]
35. Who needs to know? Confusion reigns over the reporting of gene therapy deaths. Boyce N New Sci; 1999 Nov; 164(2212):15. PubMed ID: 11885629 [No Abstract] [Full Text] [Related]
36. Clinical medicine. FDA to release data on gene therapy trials. Kaiser J Science; 2001 Jan; 291(5504):572-3. PubMed ID: 11229395 [No Abstract] [Full Text] [Related]
37. Review of NIHRAC focuses on gene therapy. Fox JL Biotechnology (N Y); 1995 May; 13(5):431-2. PubMed ID: 9634783 [No Abstract] [Full Text] [Related]
38. RAC ponders its purpose: to be or not to be. Jenks S J Natl Cancer Inst; 1993 Oct; 85(19):1544-6. PubMed ID: 8411224 [No Abstract] [Full Text] [Related]
39. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Raper SE; Yudkoff M; Chirmule N; Gao GP; Nunes F; Haskal ZJ; Furth EE; Propert KJ; Robinson MB; Magosin S; Simoes H; Speicher L; Hughes J; Tazelaar J; Wivel NA; Wilson JM; Batshaw ML Hum Gene Ther; 2002 Jan; 13(1):163-75. PubMed ID: 11779420 [TBL] [Abstract][Full Text] [Related]
40. Protecting research subjects--what must be done. Shalala D N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]